My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

33.98 +0.06 (+0.18%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

3 No-Brainer Stocks to Buy With $200 Right Now ↗

July 17, 2024

A modest amount of money can go a long way on Wall Street when it's put to work in innovation-driven businesses.

Via The Motley Fool

Here's How Much $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today ↗

July 16, 2024

Via Benzinga

FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse ↗

July 01, 2024

The FTC is investigating Teva Pharmaceuticals for alleged misuse of inhaler patents to block generic competition and maintain high prices in the U.S. while selling the same products for less overseas.

Via Benzinga

Topics Intellectual Property

Dr. Reddy's Labs Stock Sees Improved Technical Strength ↗

June 28, 2024

On Friday, Dr. Reddy's Labs ADR stock earned an upgrade to its Relative Strength (RS) Rating, from 66 to 76.

Via Investor's Business Daily

Teva Engages In Settlement Talks Over Medicare Kickback Allegations ↗

June 18, 2024

Teva Pharmaceutical is negotiating with the DOJ to settle a lawsuit alleging it paid kickbacks through charities to boost Copaxone sales, risking up to $10 billion in damages.

Via Benzinga

Topics Lawsuit

Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know ↗

June 14, 2024

Corcept Therapeutics Inc. (NASDAQ: CORT) shares are trading lower Friday afternoon following a report suggesting Teva Pharmaceuticals Inc. (NYSE: TEVA) has sued the company, accusing it of a monopoly...

Via Benzinga

Topics Lawsuit

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today ↗

June 12, 2024

Via Benzinga

4 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know ↗

May 30, 2024

Via Benzinga

Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings ↗

July 29, 2024

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting.

Via Benzinga

Topics Economy

Why Hims & Hers Heath Shares Are Surging Today ↗

July 22, 2024

Hims & Hers Health Inc. (NYSE: HIMS) shares are moving higher on Monday amidst the announcement of Kåre Schultz's appointment to the Board of Directors.

Via Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today ↗

July 19, 2024

Via Benzinga

Teva's Migraine Treatment Found Effective For Children As Young As 6 ↗

July 18, 2024

Teva Pharmaceutical's Phase 3 SPACE study reveals Ajovy's significant efficacy in preventing episodic migraines in children aged 6-17. The trial's primary endpoint was met with safety data aligning...

Via Benzinga

Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There' ↗

July 17, 2024

Jim Cramer doesn't favor Fortinet, but owns Palo Alto Networks for charity. Air Products not doing well due to better run company Linde.

Via Benzinga

Breaking Down Teva Pharmaceutical Indus: 5 Analysts Share Their Views ↗

June 27, 2024

Via Benzinga

Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know ↗

May 22, 2024

Via Benzinga

7 A-Rated Biotech Stocks Worth Betting on in June ↗

June 14, 2024

A-rated biotech stocks are highly coveted because they are at the forefront – or in the midst of -- groundbreaking innovation.

Via InvestorPlace

Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch ↗

May 18, 2024

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA).

Via Benzinga

Topics Cannabis

Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade ↗

May 16, 2024

The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics.

Via InvestorPlace

Topics Intellectual Property

These 10 Large Cap Stocks Shined Brightest Last Week (May 5-May 11, 2024): Are They In Your Portfolio? ↗

May 12, 2024

Toast, Teva, Vistra, Equinix, Applovin, IFF, Constellation, Emerson, IP, and STERIS were top performers last week. Are they in your portfolio?

Via Benzinga

Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript ↗

May 08, 2024

TEVA earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

Generics Player Teva Pharmaceutical Aces Late-Stage Schizophrenia Drug Study, Stock Shoots Higher ↗

May 08, 2024

Results from the Phase 3 SOLARIS trial of TEV-‘749 for schizophrenia treatment. SteadyTeq technology ensures controlled olanzapine release. Clinically meaningful improvements in PANSS scores observed...

Via Benzinga

Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 08, 2024

Via Benzinga

TEVA Stock Earnings: Teva Pharmaceutical Indus Misses EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

TEVA stock results show that Teva Pharmaceutical Indus missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday ↗

May 08, 2024

Via Benzinga

Teva Surges To 5-Year High On Maintained Outlook Despite Mixed First Quarter ↗

May 08, 2024

The company missed first-quarter earnings forecasts by 4 cents a share, but sales beat.

Via Investor's Business Daily

Wall Street Poised For Muted Open On Mixed Earnings, With More Fed Speeches In Store: Analyst Sees S&P 500 Crossing Late-March High ↗

May 08, 2024

U.S. stocks are on track for a mixed start on Wednesday as the market digests mixed earnings reports and looks ahead to more speeches by Federal Reserve officials.

Via Benzinga

Topics Economy Stocks

Investor Sentiment Falls Further, Dow Gains For Fifth Session ↗

May 08, 2024

Via Benzinga

Topics Stocks

Uber, Lyft And 3 Stocks To Watch Heading Into Wednesday ↗

May 08, 2024

Via Benzinga

A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation ↗

May 03, 2024

Earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation report.

Via Investor's Business Daily

Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report ↗

May 06, 2024

According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.